Video Experimental Relacionado

Updated: Jun 25, 2026

The In ovo CAM-assay as a Xenograft Model for Sarcoma
12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 18, 2013

La biopsia del ganglio centinela en el cáncer de mama.

I A Rowe

    Lancet (London, England)
    |December 6, 2001
    PubMed
    Resumen

    No abstract available in PubMed .

    Más Videos Relacionados

    Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
    07:59

    Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

    Published on: September 3, 2021

    Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
    07:45

    Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

    Published on: January 26, 2024

    Videos de Experimentos Relacionados

    Last Updated: Jun 25, 2026

    The In ovo CAM-assay as a Xenograft Model for Sarcoma
    12:44

    The In ovo CAM-assay as a Xenograft Model for Sarcoma

    Published on: July 18, 2013

    Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
    07:59

    Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

    Published on: September 3, 2021

    Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
    07:45

    Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis

    Published on: January 26, 2024

    Videos de Conceptos Relacionados

    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

    Risk Factors for Liver Disease Cluster Geographically: A Precision Public Health Analysis of a UK City.

    Alimentary pharmacology & therapeutics·2025

    Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice.

    Postgraduate medical journal·2013

    Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis.

    Alimentary pharmacology & therapeutics·2013

    Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.

    Alimentary pharmacology & therapeutics·2012

    Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit.

    Alimentary pharmacology & therapeutics·2012

    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

    Lancet (London, England)·2026

    Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

    Lancet (London, England)·2026

    Advancing the relevance of clinical trials for older patients.

    Lancet (London, England)·2026

    Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

    Lancet (London, England)·2026

    Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

    Lancet (London, England)·2026

    Patterns of Colorectal Cancer Diagnosis in Older Adults: A SEER-Medicare Analysis of Health and Economic Impact of Missed Screening Opportunities.

    Journal of surgical oncology·2026

    US real-world biomarker testing differences and treatment choice in advanced ovarian cancer: results of a retrospective study.

    Future oncology (London, England)·2026

    Renal Dysfunction Across Etiologies of Chronic Liver Disease: A Cross-Sectional Study From a Tertiary Care Center.

    Cureus·2026

    A Case of Cecal Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm Requiring Adjuvant Chemotherapy Based on Comprehensive Pathological Assessment.

    Surgical case reports·2026

    Epitranscriptomic control of epithelial-mesenchymal transition in cancer: mechanisms, plasticity, and therapeutic opportunities.

    Frontiers in cell and developmental biology·2026

    A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support.

    Frontiers in artificial intelligence·2026
    Ver todos los artículos relacionados
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ACERCA DE JoVE
    Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
    AUTORES
    Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
    BIBLIOTECARIOS
    TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
    INVESTIGACIÓN
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
    EDUCACIÓN
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
    Términos y Condiciones de Uso
    Política de Privacidad
    Políticas
    Jove
    Visualize
    Contáctanos